1. A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
   Devahuti Chaliha et al, 2020, Developmental Neuroscience CrossRef
2. Protective Effect of Nimodipine Against Valproic-acid Induced Biochemical and Behavioral Phenotypes of Autism
   Hariom Kumar et al, 2022, Clinical Psychopharmacology and Neuroscience CrossRef
3. Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
   David Zarate-Lopez et al, 2024, Current Neuropharmacology CrossRef
4. Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats
   Liyan Qin et al, 2016, Molecular and Cellular Neuroscience CrossRef
5. N-acetylcysteine ameliorates repetitive/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism
   Yinghua Zhang et al, 2017, Molecular Medicine Reports CrossRef
6. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes
   Mahdi Rizk et al, 2021, Molecular Biology Reports CrossRef
7. Synaptic Wnt/GSK3βSignaling Hub in Autism
   Mario O. Caracci et al, 2016, Neural Plasticity CrossRef
8. Fingolimod (FTY720) attenuates social deficits, learning and memory impairments, neuronal loss and neuroinflammation in the rat model of autism
   Hongmei Wu et al, 2017, Life Sciences CrossRef
9. Role of Oxidative Stress and Antioxidants in Autism
   Thamilarasan Manivasagam et al, 2020, Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management CrossRef
10. The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment
    Bo Zhou et al, 2022, Frontiers in Neuroscience CrossRef
11. Leptin and camel milk abate oxidative stress status, genotoxicity induced in valproic acid rat model of autism
    Mohamed A Hamzawy et al, 2018, International Journal of Immunopathology and Pharmacology CrossRef
12. Sumac and gallic acid‐loaded nanophytosomes ameliorate hippocampal oxidative stress via regulation of Nrf2/Keap1 pathway in autistic rats
    Haniyeh Abbasalipour et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
13. Antioxidant system alterations and physiological characteristics of neonatal and juvenile DAT‐KO rats
    S. A. Apryatin et al, 2023, Journal of Neuroscience Research CrossRef
14. CTNNB1 in neurodevelopmental disorders
    Wenting Zhuang et al, 2023, Frontiers in Psychiatry CrossRef
15. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism
    Md. Mamun Al-Amin et al, 2015, Behavioural Brain Research CrossRef
16. Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
    Hsiao-Ying Kuo et al, 2018, Frontiers in Cellular Neuroscience CrossRef
17. Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers
    Xukun Liu et al, 2022, Frontiers in Psychiatry CrossRef
18. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments
    Maria Jimena Salcedo-Arellano et al, 2021, Neurotherapeutics CrossRef
19. Hydroalcoholic extract of Passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism
    Fatemeh Amini et al, 2023, Journal of Traditional and Complementary Medicine CrossRef